Strain Profile and Chemistry
Tangerine sours is a hybrid cannabis cultivar known for a citrus-forward aroma and a balanced THC-to-CBD ratio that typically ranges between 18% and 24% THC with CBD levels often below 1%, according to lab results shared by licensed producers and testing platforms. The terpene profile commonly highlights limonene, myrcene, and caryophyllene, which contribute to the fruity, sour scent and are frequently cited in strain databases and third-party certificate of analysis reports. The cross is often traced to a lineage involving tangie-descended genetics and a sour-type phenotype, and it is marketed by brands that emphasize consistent batch-to-batch potency testing and transparent labeling.
Consumer interest in tangerine sours has grown as more legal states adopt mandatory potency and contaminant testing, with data from cannabis analytics firms showing that strains in the 18% to 24% THC range remain among the most frequently purchased in regulated dispensaries. The cultivar's name and flavor profile are designed to signal a specific sensory experience, and its market positioning often highlights the interplay between terpene-driven aroma and reported effects such as uplift and relaxation, which are described in product descriptions and user reviews on licensed platforms.
Market Pricing and Retail Distribution
As of the latest publicly available retail data, tangerine sours flower is typically priced in the mid-to-upper tier for legal markets, with grams often ranging from 10 to 18 USD depending on state taxes, licensing fees, and local supply-demand dynamics, while prerolls and concentrates may carry different price points based on processing methods and packaging. Licensed producers and distributors list the strain in inventory systems across multiple legal states, and price fluctuations are tracked by industry analysts who monitor wholesale and retail data to identify trends in consumer preference for citrus and sour flavor profiles.
Retail availability is concentrated in states with mature medical and adult-use frameworks, and product listings often include batch-specific test results for cannabinoids, terpenes, and residual solvents, which are required by state regulations and displayed on packaging or digital menus. The strain's presence in multi-state operators' portfolios reflects broader industry consolidation trends, where companies leverage data on terpene preferences and potency tiers to optimize shelf space and marketing spend across dispensary networks.
Regulatory and Compliance Context
Tangerine sours is subject to the same testing, labeling, and packaging rules as other cannabis flower in legal jurisdictions, with requirements that vary by state but commonly include limits on pesticides, heavy metals, mold, and residual solvents, as well as child-resistant packaging and potency disclosure on the label. In states such as Colorado and California, regulatory agencies publish rules that define allowable THC and CBD ranges, testing methods, and packaging standards, and licensed processors must comply with these rules to sell flower, prerolls, and infused products containing the cultivar.
Federal classification remains a key factor for banking, interstate commerce, and research access, and the strain's legal status is tied to the broader regulatory landscape that includes the 2018 Farm Bill's hemp definitions and ongoing state-level legislative changes. Industry participants track federal and state rulemaking through official government portals and trade association updates, and compliance teams use these resources to ensure that tangerine sours products meet evolving standards for testing, labeling, and sales restrictions in each market where the cultivar is available.